Pfizer Triples Profits to $767 Million
February 3, 2010
Raw Story
By AFP
Pharmaceutical giant Pfizer said Wednesday fourth-quarter net income nearly tripled from a year ago to 767 million dollars, boosted by the acquisition of rival drugmaker Wyeth.
Pfizer, the maker of blockbuster cholesterol treatment Lipitor and Viagra for erectile dysfunction, said the results pushed its yearly profit for 2009 up seven percent to 8.6 billion dollars.
Revenues for the world’s biggest drugmaker rose 16 percent in the October-December period to 16.5 billion dollars, and for the year were up four percent to 50 billion dollars.
“During the fourth quarter, we closed the Wyeth acquisition and immediately began the integration of our operations, advancing the transformation of the company,” Pfizer chairman and chief executive Jeff Kindler said in a statement.
“We are pleased with the rapid pace of the integration and our ability to quickly realize the benefits of our combined organization. We remain excited about our more diverse in-line product and pipeline portfolio, which we expect will result in improved opportunities for the company in 2010 and beyond.”
The fourth quarter results amounted to a profit of 49 cents a share excluding special items, a penny below Wall Street forecasts. Revenues meanwhile were better than expected.
The jump in profits in the quarter also reflected the prior year’s charges due to litigation over its pain medications Bextra and Celebrex, and from cost cutting. Another factor was the divestment of biotech unit Vicuron required under the Wyeth tie-up.
The company’s 2010 outlook was below forecasts calling for per-share profit in a range of 2.10 to 2.20 dollars instead of 2.27 dollars expected. But its revenue outlook was better than anticipated, a range of 67 to 69 billion dollars.
Click here for the full report.
The Kevin Trudeau Show: 11-25-09
Today, Kevin gives you the latest headline news you won’t hear in the main stream media!
Big Pharma Scandal
Vaccines Proven Useless
Female Viagra Joke
Plus, the water doctor, Fred Van Liew, gives you the inside details of what is really lurking in your water and what you can do to bring the life back into your water! Click here to purchase his life changing book, Adrenal Exhaustion & Chronic Fatigue: How To Stop The Nightmare!
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
Click below to hear The Kevin Trudeau Show RIGHT NOW!!!
Viagra for Women?
November 25, 2009
Breitbart
A drug that failed to fight the blues could be the female answer to the little blue pill Viagra, the lead North American investigator analysing tests of the drug said Tuesday.
Women who took the drug flibanserin when it was being tested as an anti-depressant said it didn’t help them beat the glums, but did give them “an increase in libido that they liked,” John Thorp, one of the investigators analyzing data from three clinical trials of the drug, told AFP.
Lack of desire is the most common sexual problem in women aged 30 to 60, just as erectile dysfunction, for which Viagra is one of a choice of treatments, is the most common sexual disorder among men in the same age bracket, Thorp said.
“Men remain interested but can’t act or perform properly and women lose interest,” said Thorp.
“So where Viagra and other erectile dysfunction medications work in the blood supply, flibanserin works in the brain,” he said.
In the light of the women’s reactions to flibanserin, the German drug company that had first tested the drug as a treatment for depression, Boehringer Ingelheim, several years ago began exploring the possibilities of it being the active ingredient in the female answer to Viagra.
Clinical trials were held in Canada, Europe and the United States to test the drug’s efficacy in raising the level of sexual desire in women.
Nearly 2,000 pre-menopausal women were given flibanserin or a placebo for 24 weeks and asked to report back to researchers or make diary entries on six variables, including the number of satisfactory sexual encounters they had and their level of sexual desire.
The studies found that 100 milligrams a day of flibanserin resulted in “significant improvements” in the two variables.
Flibanserin is currently an investigational drug and is only available to women taking part in clinical trials.
Click here for the full report
Misbranding drugs leads to Pfizer paying $1.3 billion in criminal fines
October 19, 2009
Natural News
By Mike Adams
In the largest criminal fine ever levied against any drug company in the world, a unit of U.S.-based Pfizer, Inc. was sentenced to pay $1.3 billion in criminal fines and revenue forfeiture. It’s all part of a $2.3 billion settlement announced by the Justice Department. The case centers around Pfizer’s criminal “off-label marketing” of four drugs, including the painkiller Bextra. After whistleblowers filed lawsuits in three states, the U.S. Justice Department took an interest in the case and prosecuted Pfizer for criminal acts.
In the settlement, Pfizer admitted to a felony crime and agreed to pay $2.3 billion in fines and other fees. The investigation of Pfizer reportedly turned up evidence that Pfizer engaged in kickback payments to doctors for nine drugs, including Viagra and Lipitor.
Part of the reason the penalty against Pfizer was so large is because the company was considered a “repeat offender” in promoting drugs for unapproved uses (which is a violation of federal law).
Off-label marketing makes a mockery of modern medicine
So-called “off-label” marketing of drugs is rampant in the pharmaceutical industry. Although the FDA, drug companies and many conventional doctors claim the drug industry is guided by a “gold standard” of scientific scrutiny, the truth is that pharmaceuticals are routinely marketed and prescribed for health conditions for which they have never even been studied… much less actually approved by the FDA. The fact that this continues today makes a mockery of any “scientific credibility” the pharmaceutical industry claims to possess.
Drug companies take advantage of this gaping hole in regulatory oversight by getting their drugs approved by the FDA for one health condition, then heavily promoting it for numerous unrelated conditions. A drug approved for high blood pressure, for example, could be openly marketed for diabetes or Alzheimer’s disease even though there is no evidence whatsoever showing the drug to be either safe or effective for such conditions.
The same is true with the intended demographics of pharmaceuticals: Drug companies often get their drugs approved for adults, then they market those drugs to children even though the drugs have never been tested with children.
The result is a pharmaceutical industry that appears to be highly regulated, but isn’t. Virtually any drug can be pushed for any disease for almost any reason — all with virtually no oversight by the FDA. In fact, in this Pfizer case, even with the Justice Department filing criminal charges against Pfizer, the FDA has stood by and done absolutely nothing to prevent such actions from being repeated in the future by Pfizer or another drug company.
Click here for full report from Natural News
What Would You Choose? Viagra or Implant Surgery?
October 15, 2009
Abc News
By Joseph Brownstein
People may be used to getting spam e-mails offering discounts on Cialis, Levitra or Viagra, but if a new clinical trial is successful, men with erectile dysfunction may someday be flooded with e-mails for another option: a stent.
Medtronic has begun testing on a new pelvic stent for men who have not been helped by drugs. Investigators will begin with 50 patients at 10 different medical centers.
“This is a common problem. Men many times do not have satisfactory results from first-line medical therapies,” said Dr. Krishna Rocha-Singh, director of the Prairie Vascular Institute in Springfield, Ill., who installed the first of the stents in a patient last week.
Singh said erectile dysfunction can also be a sign of larger problems, with potential blockages of major blood vessels.
“Erectile dysfunction could be a symptom of a vascular source,” he said, noting that it could be an early sign of what could lead to heart attacks or strokes. “The patients we’re treating in our practice [with erectile dysfunction] had the same problem elsewhere in other parts of the body.”
By opening up blood flow, Singh explained, stenting might solve some of those problems. However, he pointed out, it remains to be seen which patients would be helped by the stent, a question he hopes the clinical trial will answer.
Other doctors in the field said the device may prove beneficial, but only to a small subset of men.
Best for Younger Men?
Dr. Jerome Richie, the chief of urology at Brigham and Women’s Hospital in Boston, said, “I would foresee this stent as an application for younger individuals who have had traumatic injuries that decrease arterial inflow. Other than that selected group, I do not foresee widespread applicability.”
Dr. Ajay Nehra, a professor of urology at the Mayo Clinic, agreed that young men whose erectile dysfunction stemmed from traumatic injury would be the most likely to be helped, and said they may prefer a stenting operation to a pill, since an erection would not feel as medically induced later on.
“Men would ideally like to have natural, spontaneous erection, and that’s why the medical device is trying to look at alternative options than pills, per se,” said Nehra.
Will There Be Demand?
For many men with erectile dysfunction, the available pills do not help. For that reason, a number of doctors thought the stent could become a commercial success.
I’ve got your Erectile Dysfunction cure
September 29, 2009 by KT
Filed under Kevin's Blog
If you know someone in their 30’s, 40’s or 50’s suffering from erectile dysfunction, they have a serious medical problem. They need to wake up because you should be in your 70’s and 80’s and never have erectile dysfunction issues. And if they do, take notes…
What’s the cause of this problem?
* Mental and emotional stress. You need to do the thought field therapy techniques to resolve this issue.
* Diabetes. Someone may say, “I’m not diabetic.” Well, how do you know? You’re probably pre-diabetic. This is a major issue and you need to take control of it. Eleotin cures diabetes and that in itself almost always handles erectile dysfunction. If you don’t handle the diabetic issue or the pre-diabetic issue, you’re not going to solve the problem.
* High blood pressure. If you have high blood pressure issues, that’s going to cause problems with erectile dysfunction. So you need to address that, but never take the drugs prescribed for high blood pressure. In my book, More Natural Cures Revealed, I give you a whole bunch of cures for high blood pressure!
* Non-prescription and prescription drugs. Every single non-prescription and prescription drug can cause erectile dysfunction and the answer is not another drug.
* Circulation could be a major factor. You could have blockages in your arteries. You need to do either oral chelation or intravenous chelation. I would also use live cell therapy and the high precursors from AbleHeal.
* I would also take Vitamin E and not just any vitamin E; you’ve got to take the three brands that I recommend. There are also some herbs that are very powerful. Yohimbe and maca are two very powerful ones. Ginseng can also help a little bit. Chiropractic adjustments, surprisingly, can also help with getting energy flow back to that area in the male. Acupuncture is very effective. Alphabiotics is very effective.
When you address those causes the problem will be cured. Animals in the wild don’t have erectile dysfunction. Think about it. Our closest cousins, gorillas and chimpanzees, never have erectile dysfunction issues. They also don’t take any drugs. They don’t need Viagra. They’re fathering children in human years in their 90’s. Male gorillas have no erectile dysfunction ever in their life. But you, you’re 35 or 40 and already have erectile dysfunction.
Folks, you got to open your eyes, there is a major problem here!
Yours in health,
KT
